Blog

RSS Feed
Posted by Michael Wonder on 21 Nov 2019

FDA takes second action under international collaboration, approves new treatment option for patients with chronic lymphocytic leukaemia

21 November 2019 - Today, as part of Project Orbis, a collaboration with the Australian Therapeutic Goods Administration and Health Canada, ...

Read more →
Posted by Michael Wonder on 09 Apr 2019

Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews

9 April 2019 - Canadians want improved access to the most recent and innovative treatment options for themselves and their ...

Read more →
Posted by Michael Wonder on 27 Jun 2018

Health Canada offers HTA aligned reviews for drugs and biologics

25 June 2018 - Sponsors of biologics and new drug submissions now have the option of requesting aligned regulatory reviews ...

Read more →
Posted by Michael Wonder on 26 Apr 2018

Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada

26 April 2018 - The clinical development of cancer therapeutics is a global undertaking, and incorporation of the patient experience into ...

Read more →